Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 140OTHER 125NIH 33NETWORK 4OTHER_GOV 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4Head & Neck 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 3Carcinoma, Squamous Cell 3Carcinoma, Basal Cell 3Skin Neoplasms 2Sezary Syndrome 2Mycosis Fungoides 2Keratosis, Actinic 2Skin Diseases 1Patient Compliance 1Neoplasms, Squamous Cell 1Neoplasms, Basal Cell 1Neoplasms by Site 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Carcinoma 1

Interventions

ADI PEG20 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Neoplasm Metastasis × Dermatologic × Clear all
NCT00029900 2015-03-25

ADI-PEG in Patients With Metastatic Melanoma

FDA Office of Orphan Products Development

Phase 1 Completed
15 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡